# Charles J. Ferro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-j-ferro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,008 |
| Field | Dialysis and Renal Disease Management |
| h-index | 55 |
| i10-index | 184 |
| Last Known Institution | University Hospitals Birmingham NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5049930083 |
| ORCID iD | 0000-0003-0577-7081 |
| Works | 375 |

## Researcher papers

- [2024 ESC Guidelines for the management of elevated blood pressure and hypertension](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and/)
- [Chronic Kidney Disease and Coronary Artery Disease](https://scholariq.org/papers/chronic-kidney-disease-and-coronary-artery-disease/)
- [Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association](https://scholariq.org/papers/cardiovascular-complications-in-chronic-kidney-disease-a-review-from-the/)
- [Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in Humans](https://scholariq.org/papers/systemic-endothelin-receptor-blockade-decreases-peripheral-vascular-resistance/)
- [Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease](https://scholariq.org/papers/effect-of-spironolactone-on-left-ventricular-mass-and-aortic-stiffness-in-early/)
- [Lipid management in patients with chronic kidney disease](https://scholariq.org/papers/lipid-management-in-patients-with-chronic-kidney-disease/)
- [Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*](https://scholariq.org/papers/hypertension-in-dialysis-patients-a-consensus-document-by-the-european-renal-and/)
- [Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis](https://scholariq.org/papers/effect-of-mineralocorticoid-receptor-antagonists-on-proteinuria-and-progression/)
- [SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA](https://scholariq.org/papers/sglt-2-inhibitors-and-glp-1-receptor-agonists-for-nephroprotection-and/)
- [A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: A European Palliative Care Research Collaborative opioid guidelines project](https://scholariq.org/papers/a-systematic-review-of-the-use-of-opioid-medication-for-those-with-moderate-to/)
- [The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease](https://scholariq.org/papers/the-effect-of-spironolactone-upon-corticosteroid-hormone-metabolism-in-patients/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Researcher university

- [University Hospitals Birmingham NHS Foundation Trust](https://scholariq.org/institutions/university-hospitals-birmingham-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.